Global Veress Needle Market Size By Type (120mm, 150mm), By Application (Laparoscopic Surgery, Others), By Region, And Segment Forecasts, 2023 to 2032

The Global Veress Needle Market was valued at USD 280 million in 2023 and is projected to surpass USD 470 million by 2031, growing at a CAGR of 6.8% during the forecast period (2023-2031). The market is driven by the increasing prevalence of minimally invasive surgical procedures, particularly in laparoscopy. Veress needles are crucial medical instruments used for creating pneumoperitoneum in laparoscopic surgeries, which is fueling their demand. The growing number of laparoscopic surgeries, increasing technological advancements, and the rising adoption of minimally invasive procedures contribute significantly to market expansion.

Drivers:

Increasing Demand for Minimally Invasive Surgeries

Laparoscopic procedures are gaining popularity due to reduced hospital stays, minimal scarring, and lower risks of complications. This trend is driving the demand for Veress needles, which are essential for establishing pneumoperitoneum in these surgeries.

Advancements in Surgical Technologies

The development of safety-enhanced Veress needles with pressure sensors and real-time monitoring is making laparoscopic procedures safer, thereby increasing adoption.

Growing Geriatric Population and Rising Cases of Chronic Diseases

The increasing prevalence of gastrointestinal disorders, obesity-related surgeries, and gynecological procedures is driving market growth.

Restraints:

Risks Associated with Veress Needle Insertion

Although widely used, Veress needles pose risks of visceral and vascular injuries, which may limit their adoption in some surgical settings.

Availability of Alternative Techniques

The introduction of direct trocar insertion (DTI) and optical trocars as alternatives to Veress needles could restrict market growth.

Opportunity:

Expansion into Emerging Markets

Developing countries in Asia-Pacific and Latin America are witnessing increased investments in healthcare infrastructure, creating opportunities for Veress needle manufacturers.

Integration with Smart Technologies

The development of Veress needles with real-time pressure sensors and safety indicators can enhance safety and increase market penetration.

Market by System Type Insights:

Standard Veress Needles:

These remain the most widely used type due to cost-effectiveness and ease of use.

Preferred in routine laparoscopic surgeries.

Safety-Enhanced Veress Needles:

Equipped with pressure monitoring systems to minimize injury risks.

Increasing adoption in advanced hospitals and surgical centers.

Market by End-Use Insights:

Hospitals:

Accounted for the largest market share in 2023, driven by the increasing number of laparoscopic procedures performed in hospitals.

Equipped with specialized surgical units, making them primary users of Veress needles.

Ambulatory Surgical Centers (ASCs):

Expected to witness the fastest growth, due to the rising preference for outpatient minimally invasive surgeries.

Market by Regional Insights:

North America:

Held the largest share in 2023, driven by high adoption of laparoscopic procedures and technological advancements in surgical equipment.

Europe:

Strong presence of medical device manufacturers and increasing demand for minimally invasive procedures.

Asia-Pacific:

Fastest-growing region due to rising healthcare investments, increasing medical tourism, and expanding laparoscopic surgery adoption in China, India, and Japan.

Competitive Scenario:

Key players in the Global Veress Needle Market include:

Medtronic Plc

Johnson & Johnson (Ethicon Inc.)

B. Braun Melsungen AG

CONMED Corporation

Genicon, Inc.

Stryker Corporation

Applied Medical Resources Corporation

These companies are focusing on product innovations, acquisitions, and expanding their geographic presence to gain a competitive edge.

Scope of Work – Global Veress Needle Market

Key Market Developments:

Medtronic Plc launched a new range of Veress needles in 2023 with enhanced safety features and real-time pressure monitoring to reduce insertion risks.

Johnson & Johnson (Ethicon Inc.) partnered with a leading healthcare provider in 2024 to integrate its Veress needles into advanced robotic-assisted laparoscopic surgeries.

B. Braun Melsungen AG announced an investment of $50 million in 2025 to expand its surgical instrument manufacturing capacity in Europe and Asia.

FAQs

What is the current market size of the Global Veress Needle Market?

The Global Veress Needle Market was valued at USD 280 million in 2023.

What is the major growth driver of the Global Veress Needle Market?

The market is driven by the increasing demand for minimally invasive laparoscopic surgeries.

Which region is the largest market for Veress needles?

North America dominates the market due to technological advancements and high adoption rates in surgical procedures.

Which segment accounted for the largest market share in the Global Veress Needle Market?

The Standard Veress Needle segment accounted for the largest market share in 2023.

Who are the key market players in the Global Veress Needle Market?

Key players include Medtronic, Johnson & Johnson (Ethicon), B. Braun Melsungen, CONMED Corporation, and Stryker Corporation.

Conclusion

The Global Veress Needle Market is witnessing steady growth, driven by the rising adoption of minimally invasive surgeries and technological advancements in surgical instruments. While safety concerns and alternative techniques pose challenges, opportunities in emerging markets and smart technology integration are expected to drive further expansion. Market leaders are investing in R&D and forming strategic partnerships to enhance their market position.